BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15389225)

  • 1. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
    Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F;
    Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention.
    Straumann E; Kurz DJ; Muntwyler J; Stettler I; Furrer M; Naegeli B; Frielingsdorf J; Schuiki E; Mury R; Bertel O; Spinas GA
    Am Heart J; 2005 Nov; 150(5):1000-6. PubMed ID: 16290985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of admission glucose on epicardial and microvascular flow after primary angioplasty.
    Shen XH; Jia SQ; Li HW
    Chin Med J (Engl); 2006 Jan; 119(2):95-102. PubMed ID: 16454990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of admission blood glucose levels on the short term mortality in patients with acute ST-segment elevation myocardial infarction].
    Yang YM; Liu Y; Zhu J; Tan HQ; Liang Y; Li Y; Li JD; Zhang Y; Liu LS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1230-3. PubMed ID: 19595174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia.
    Timmer JR; Ottervanger JP; Hoorntje JC; De Boer MJ; Suryapranata H; van 't Hof AW; Zijlstra F;
    J Intern Med; 2005 May; 257(5):423-9. PubMed ID: 15836658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty.
    Worthley MI; Shrive FM; Anderson TJ; Traboulsi M
    Am J Med; 2007 Jul; 120(7):643.e1-7. PubMed ID: 17602940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era.
    Ishihara M; Kagawa E; Inoue I; Kawagoe T; Shimatani Y; Kurisu S; Nakama Y; Maruhashi T; Ookawa K; Dai K; Aokage Y
    Am J Cardiol; 2007 Jun; 99(12):1674-9. PubMed ID: 17560874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
    Stranders I; Diamant M; van Gelder RE; Spruijt HJ; Twisk JW; Heine RJ; Visser FC
    Arch Intern Med; 2004 May; 164(9):982-8. PubMed ID: 15136307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue percutaneous coronary intervention after failed thrombolysis: results from the Acute Coronary Syndrome Israel Surveys (ACSIS).
    Yalonetsky S; Gruberg L; Sandach A; Hammerman H; Beyar R; Hod H; Behar S
    Acute Card Care; 2006; 8(2):83-6. PubMed ID: 16885071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term follow-up of patients treated with intracoronary thrombolysis or percutaneous transluminal coronary angioplasty for acute myocardial infarction].
    Mori T; Nosaka H; Kimura T; Nobuyoshi M
    J Cardiol; 1991; 21(2):323-36. PubMed ID: 1841920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
    Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W
    Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.